These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 25264224)
1. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis. Zhou C; Sun B Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224 [TBL] [Abstract][Full Text] [Related]
2. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595 [TBL] [Abstract][Full Text] [Related]
3. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China. Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156 [TBL] [Abstract][Full Text] [Related]
4. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas. Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751 [TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study. Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077 [TBL] [Abstract][Full Text] [Related]
6. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties. Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460 [TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis. Dong Y; Ochsenreither S; Cai C; Kaufmann AM; Albers AE; Qian X PLoS One; 2017; 12(11):e0187615. PubMed ID: 29112953 [TBL] [Abstract][Full Text] [Related]
8. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer. Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750 [TBL] [Abstract][Full Text] [Related]
9. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors. Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256 [TBL] [Abstract][Full Text] [Related]
10. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607 [TBL] [Abstract][Full Text] [Related]
11. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis. Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601 [TBL] [Abstract][Full Text] [Related]
12. ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis. Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687 [TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma. Wu Q; Shi H; Holm R; Li X; Trope C; Nesland JM; Suo Z Anticancer Res; 2014 Feb; 34(2):859-65. PubMed ID: 24511023 [TBL] [Abstract][Full Text] [Related]
14. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence. Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H; Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476 [TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Minato T; Yamamoto Y; Seike J; Yoshida T; Yamai H; Takechi H; Yuasa Y; Furukita Y; Goto M; Bando Y; Tangoku A Ann Surg Oncol; 2013 Jan; 20(1):209-17. PubMed ID: 22847125 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Chen YC; Chang CJ; Hsu HS; Chen YW; Tai LK; Tseng LM; Chiou GY; Chang SC; Kao SY; Chiou SH; Lo WL Oral Oncol; 2010 Mar; 46(3):158-65. PubMed ID: 20036608 [TBL] [Abstract][Full Text] [Related]
17. ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status. Qian X; Wagner S; Ma C; Klussmann JP; Hummel M; Kaufmann AM; Albers AE Oncol Rep; 2013 May; 29(5):1777-84. PubMed ID: 23483187 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome. Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K Oncology; 2012; 82(3):168-74. PubMed ID: 22433454 [TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase 1: a specific cancer stem cell marker for human colorectal carcinoma. Zhou F; Mu YD; Liang J; Liu ZX; Zhou D; Ning WL; Li YZ; Ding D; Zhang JF Mol Med Rep; 2015 May; 11(5):3894-9. PubMed ID: 25585687 [TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]